Where does TriVascular, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), TriVascular, Inc. ranks #5,803 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does TriVascular, Inc. hold?

TriVascular, Inc. holds 59 US utility patents granted between 2015 and 2025, spanning 11 technology areas.

What is TriVascular, Inc.'s Innovation Score?

TriVascular, Inc. has an Innovation Score of 39.9 out of 100 (top 37% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is TriVascular, Inc.'s patent grant rate increasing or decreasing?

TriVascular, Inc.'s recent grant velocity is -7% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for TriVascular, Inc.'s patents?

TriVascular, Inc.'s patents average 17.5 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the TriVascular, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

TriVascular, Inc.

Q: What technology areas does TriVascular, Inc. focus on?

TriVascular, Inc.'s top technology area is A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive DEVICES; FOMENTATION; Treatment OR Protection OF Eyes OR EARS; Bandages, Dressings OR Absorbent PADS; Firs) with 55 patents, ranking #104 of 3,082 assignees active in that subclass. Grants appear in 11 CPC subclasses total.

USPTO PatentsView assignee record - 59 granted patents across 11 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Trivascular ranks #5,803 of 49,997 tracked US assignees by granted-patent volume, with 59 patents across 11 technology areas.

#5,803
of 49,997 US assignees by volume: Top 37%
by Innovation Score (39.9/100): 17.5
avg claims per patent: -7%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R5803 · US Corporation #5,803 · 59 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-FOCUS · INNOV-THIN · CLAIMS-RICH · TYPE-USCORP · VEL-FLAT · BOOK-FULL

GRANTS-SMALL 59 grants
UPPER-Q #5,803/49,997
PHOTO-FINISH Spectra Logic
CPC-FOCUS A61F · 11 areas
INNOV-THIN 39.9/100
CLAIMS-RICH 17.5 claims/avg
TYPE-USCORP US Corporation
VEL-FLAT -7% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Spectra Logic Corporation (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Trivascular’s 39.9 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 14.1 pts (35%) Velocity 3.5 pts (9%) Breadth 11.7 pts (29%) Claim depth 10.5 pts (26%)

Qualcomm Incorporated · highest

85
Pac Tech—Packaging · near

40
RED COM · near

40
TriVascular · this assignee

40
Sirna Therapeutics · near

40
Venus Medtech… · near

40
3D Lighting… · lowest

7

What this shows Trivascular's Innovation Score is 39.9/100 (top 37% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Trivascular?

Each dot is one of Trivascular’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Trivascular’s own 17.5 claims/patent is ABOVE the 16.2 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Trivascular vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Trivascular's grants concentrate

TriVascular, Inc. is a focused PatentsView assignee: 11 CPC subclasses with 93.2% of grants classified under A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device). Peak complete grant year is 2021 (9 grants) versus a trough of 3 in 2019. By volume, Trivascular sits between Spectra Logic Corporation and Wanhua Chemical Group Co., Ltd..

Trivascular's three-year grant acceleration

TriVascular, Inc. shows 10 grants in 2022–2024 against only 19 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Spectra Logic

59
THE William M Yar…

59
Tela Innovations

59
The University of…

59
Tufts Medical Cen…

59
Vodafone

59
Ventana Micro Sys…

59
Wanhua Chemical G…

59
Trivascular ◀

59

What this shows TriVascular holds 59 patents at rank #5,802, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near TriVascular

By rank, the assignees closest to #5,802 in granted patent volume.

Leaders in A61F (Filters Implantable Into Blood Vessels)

Other assignees with the most granted patents in TriVascular's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for TriVascular, neither rank-band nor same-CPC leaders (those blocks stay above). In A61F (Filters Implantable Into Blood Vessels), TriVascular ranks #104 of 3,082 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (40 here).

RED.COM, LLC 40 Pac Tech—Packaging Technologies Gmbh 40 Venus Medtech (HANGZHOU), Inc. 40 Sirna Therapeutics, Inc. 40

Similar claim depth

Nearest assignees by average claims per patent (17.5 here).

George Mason University 17.5 avg ST. Jude Medical International Holding S.Á R.L. 17.5 avg E.G.O. Elektro-Geraetebau GmbH 17.5 avg Arctic Cat Inc. 17.5 avg

Trivascular's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

40 Top 37% higher than 63% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

TriVascular, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	7	11.9%
2016	6	10.2%
2017	6	10.2%
2018	6	10.2%
2019	3	5.1%
2020	7	11.9%
2021	9	15.3%
2022	3	5.1%
2023	3	5.1%
2024	4	6.8%
2025partial year	5	8.5%

Which technologies does TriVascular, Inc. patent most?

A61F - Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive DEVICES; FOMENTATION; Treatment OR Protection OF Eyes OR EARS; Bandages, Dressings OR Absorbent PADS; Firs 55

Y10T - Technical Subjects Covered BY Former US Classification 14

A61L - Methods OR Apparatus FOR Sterilising Materials OR Objects IN GENERAL; Disinfection, Sterilisation OR Deodorisation OF AIR; Chemical Aspects OF Bandages, Dressings, Absorbent Pads OR Surgical ARTICLES; Materials FOR Bandages, Dressings, Absorbent Pads OR Surgical Articles 10

B29C - Shaping OR Joining OF PLASTICS; Shaping OF Material IN A Plastic State, NOT Otherwise Provided FOR; After-treatment OF THE Shaped Products, e.g. Repairing 6

B29L - Indexing Scheme Associated With Subclass B29c, Relating TO Particular Articles 5

A61M - Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor 5

B29K - Indexing Scheme Associated With Subclasses B29b, B29c OR B29d, Relating TO Moulding Materials OR TO Materials FOR ; Moulds, ; Reinforcements, Fillers OR Preformed Parts, e.g. Inserts 4

A61B - DIAGNOSIS; SURGERY; Identification 3

F04C - Rotary-piston, OR Oscillating-piston, Positive-displacement Machines FOR Liquids ; Rotary-piston, OR Oscillating-piston, Positive-displacement Pumps 3

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 2

G01M - Testing Static OR Dynamic Balance OF Machines OR STRUCTURES; Testing OF Structures OR Apparatus, NOT Otherwise Provided FOR 1

Top 11 of 11 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

TriVascular, Inc.'s patent record in context - here's where to go next.

TriVascular, Inc.'s lead technology class is A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device), 93.2% of its portfolio - see every assignee active in that class. Explore A61F
Ranked #5,803 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare TriVascular, Inc. against Spectra Logic Corporation, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 39.9/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.